Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
They are designated at type I (slow twitch) and type II (fast twitch)
suggesting this pathway may be a useful therapeutic target in inflammatory diseases such as asthma
It belongs
including myofibril necrosis in myopathies and in myocardial ischemia
Anti-human VEGFR1 / FLT1 (Abbott patent Anti-Flt1 Biosimilar) Size:1 mg They are designated at typeApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name VEGFR1 FLT1 Target Uniprot P17948 Overview Catalog# BIO0411SM Product Name Anti human VEGFR1 FLT1 (Abbott patent Anti Flt1 Biosimilar) Specifications Conjugation None Clone# Abbott patent Anti Flt1 Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with
US$ 13.00
US$ 122.50
US$ 29.00
US$ 144.00
![Bitter Ordeal [Future Sight] Vampire Warrior](https://cdn.shopify.com/s/files/1/0331/1468/5484/products/ca1f4478-f3f6-5261-acf5-fc7115c1dc57.jpg?v=1739824340)
US$ 3300.00
US$ 122.50
US$ 75.00
